{"id":243403,"date":"2013-01-10T19:54:28","date_gmt":"2013-01-10T19:54:28","guid":{"rendered":"http:\/\/www.eugenesis.com\/recent-advances-in-microbiology-%e2%80%93-rapid-mycoplasma-test\/"},"modified":"2013-01-10T19:54:28","modified_gmt":"2013-01-10T19:54:28","slug":"recent-advances-in-microbiology-rapid-mycoplasma-test","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/recent-advances-in-microbiology-rapid-mycoplasma-test.php","title":{"rendered":"Recent advances in Microbiology \u2013 Rapid Mycoplasma Test"},"content":{"rendered":"<p><p>      SMis Pharmaceutical Microbiology conference taking place on      the 30th & 31st January London will provide attendees      with an expert and highly accredited speaker line who will      focus on the latest developments and procedures used in the      identification and prevention of contaminating agents,      updates on new rules and regulations and the challenges      facing the Pharmaceutical Microbiology industry.    <\/p>\n<p>      London (PRWEB UK) 9 January 2013    <\/p>\n<p>      SMi is pleased to confirm John Duguid, Principle Analytical      Scientist, Genzyme as a speaker at the upcoming event. Mr.      Duguid is currently responsible for developing, validating,      and transferring molecular biology assays for rapid microbiology and cell      differentiation application s, managing complex projects to      implement process changes, and using statistical process      control tools to implement process analytical technology for      cell therapy products    <\/p>\n<p>      He will address the selection, validation and automation of      rapid mycoplasma test, looking at how to do a selection using      a risk based approach, validation according to PhEur 2.6.7      and automation for routine testing. Attending will enable      delegates to hear    <\/p>\n<p>          Over 13 speakers from top pharma          companies that include Sanofi-Aventis, Genzyme,          GlaxoSmithKline, Pfizer, Merck and MedImmune        <\/p>\n<p>      For more information visit <a href=\"http:\/\/www.smi-online.co.uk\/goto\/pharma-microbiology59.asp\" rel=\"nofollow\">http:\/\/www.smi-online.co.uk\/goto\/pharma-microbiology59.asp<\/a>      alternatively contact Cem Tuna on +44 0 207 827 6184 or email      on ctuna(at)smi-online(dot)co(dot)uk    <\/p>\n<p>      Sonal Patel      SMi Group Ltd      0207 827 6106      Email Information    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/recent-advances-microbiology-rapid-mycoplasma-test-201035257.html;_ylt=A2KJjbxfHO9QsWgAhXz_wgt.\" title=\"Recent advances in Microbiology \u2013 Rapid Mycoplasma Test\">Recent advances in Microbiology \u2013 Rapid Mycoplasma Test<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SMis Pharmaceutical Microbiology conference taking place on the 30th &#038; 31st January London will provide attendees with an expert and highly accredited speaker line who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. London (PRWEB UK) 9 January 2013 SMi is pleased to confirm John Duguid, Principle Analytical Scientist, Genzyme as a speaker at the upcoming event <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/recent-advances-in-microbiology-rapid-mycoplasma-test.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577473],"tags":[],"class_list":["post-243403","post","type-post","status-publish","format-standard","hentry","category-microbiology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/243403"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=243403"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/243403\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=243403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=243403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=243403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}